Literature DB >> 3964322

Long-term colchicine administration leading to colchicine toxicity and death.

M N Neuss, R M McCallum, W D Brenckman, H R Silberman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3964322     DOI： 10.1002/art.1780290324

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

Review 1.  Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori.

Authors:  Oren Cohen; Garrett Locketz; Alon Y Hershko; Alexander Gorshtein; Yair Levy
Journal:  Rheumatol Int       Date:  2015-07-26       Impact factor: 2.631

2.  Two cases of acute leukopenia induced by colchicine with concurrent immunosuppressants use in Behçet's disease.

Authors:  Kyu-Yeop Lee; Do Young Kim; Jae Yong Chang; Dongsik Bang
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

3.  Accidental overdose of insufflated colchicine.

Authors:  L R Baldwin; R L Talbert; R Samples
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

4.  Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report.

Authors:  Kazusato Hara; Yushiro Endo; Midori Ishida; Yuya Fujita; Sosuke Tsuji; Ayuko Takatani; Toshimasa Shimizu; Remi Sumiyoshi; Takashi Igawa; Masataka Umeda; Shoichi Fukui; Ayako Nishino; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Kiyoshi Migita; Atsushi Kawakami; Tomohiro Koga
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 5.  Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review.

Authors:  Huai Leng Pisaniello; Mark C Fisher; Hamish Farquhar; Ana Beatriz Vargas-Santos; Catherine L Hill; Lisa K Stamp; Angelo L Gaffo
Journal:  Arthritis Res Ther       Date:  2021-04-28       Impact factor: 5.156
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.